Prostate Cancer Progression may be Delayed by Blood Vessel-Blocking Drug

A blood vessel-blocking drug called tasquinimod slowed the rate of disease progression in a clinical trial of over 200 prostate cancer patients

A blood vessel-blocking drug called tasquinimod slowed the rate of disease progression in a clinical trial of over 200 prostate cancer patients, say experts at Johns Hopkins, Roswell Park Cancer Institute and Duke University.

Tasquinimod is a so-called "anti-angiogenesis" drug that squeezes off blood supply to prostate tumors by blocking new blood vessel development. Tumors require these vast networks of blood vessels to supply nutrients.

Prostate Cancer | Cancer of Prostate - Incidence, Prevention, Causes, Symptoms & Treatment
This cancer affects men over the age of 50 years and screening with rectal examination and PSA can help both in early detection and effective treatment

The multicenter trial at seven institutions, including Johns Hopkins, enrolled prostate cancer patients whose disease had spread to take a once-daily pill for four weeks.

At six months, 57 percent of men taking tasquinimod had no disease progression as compared with 33 percent taking a placebo.

Overall, the drug added approximately 12 weeks of time that the disease did not worsen (progression-free survival).

Prostate Biopsy-Preparations-Risks-Complications-Procedure-FAQ
Encyclopedia section of medindia gives general information about prostate gland

The most common side effects included gastrointestinal problems, fatigue and bone pain, and some rare occurrences of heart attack, stroke and deep vein thrombosis.

"Given these results, we feel it is reasonable to move forward with Phase III studies. After exploring the drug as a single agent, we may study it in combination approaches with other prostate cancer drugs," said Michael Carducci, professor at the Johns Hopkins Kimmel Cancer Center, who will lead the next phase of an international study of the drug.

Benign Prostatic Hyperplasia (BPH) Causes Symptoms Diagnosis Treatment FAQs
Benign Prostatic Hyperplasia (BPH) or Benign Enlargement of Prostate (BEP) is an increase in the size of the prostate. The prostate is a walnut sized gland that is part of the male reproductive system.

The work was presented at the annual meeting of the American Society of Clinical Oncology (ASCO), June 4-8, in Chicago.

Source-ANI

Advantages of Eating Fish Foods - Health Benefits
Researchers worldwide have discovered that eating fish regularly is good for health. Regular consumption of fish may reduce the risk of diseases such as asthma, prostate cancer and eyesight.